NCT05671822
- Conditions
- HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Zhongshan Hospital, FuDan University Shanghai, Shanghai Municipality, China
Clinical trial condition
HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Explore clinical trials studying HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study